Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin added to enoxaparin and aspirin in high-risk pregnancy
IRCT20210608051518N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in high-risk pregnancy comparing Melatonin + enoxaparin + aspirin with Placebo + enoxaparin + aspirin (2 arms). Primary endpoints: Serum total antioxidant capacity, Serum malondialdehyde and 6 more. Started Jan 2022; status: completed.
02
Drugs
melatonin
03
Conditions
high-risk pregnancy
Beyond the preview
Go deeper on IRCT20210608051518N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210608051518N1.